Article
Florida Cancer Specialists & Research Institute Ranked Among Top Performing Oncology Practices in the Country for Quality, Cost Saving Measures
Key quality and savings metrics as measured within the most recent performance period from The Centers for Medicare & Medicaid Innovation (CMMI) for the Oncology Care Model (OCM) demonstrated Florida Cancer Specialists & Research Institute as a top performing oncology practice nationwide.
Fort Myers, Florida — Florida Cancer Specialists & Research Institute (FCS) reported key quality and savings metrics, as measured within the most recent performance period from The Centers for Medicare & Medicaid Innovation (CMMI) for the Oncology Care Model (OCM), with Medicare savings of approximately $31.7 million over the last 6-month performance period and more than $140 million in total savings since the OCM launched in 2016.
In this most recent feedback report issued by CMMI, the number of inpatient hospital admissions for FCS was 8% lower than other OCM practices, and the number of emergency room visits not leading to admission was 21% lower than other OCM practices in the same patient risk quartile.
At the same time, FCS has demonstrated value-based outcomes and episode-based payment initiatives partnering with commercial payers, Accountable Care Organizations, and Medicaid-Managed Care Organizations in markets across the state.
“Our value-based practice initiatives at FCS are programmatic, intentional and thoughtfully designed to be organized squarely around the patient, yielding consistent results that outpace industry benchmarks and made good on our commitment to prioritize patient outcomes and quality,” stated FCS chief executive officer Nathan H. Walcker. “I could not be prouder of our entire team and their steadfast commitment to delivering value-based oncology care in communities across our great state of Florida.”
